Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in News & Analysis

Suzhou Zanrong Completes $20 Million A+ Round for Cancer Drugs
Innovent Reports Positive Data from Phase III Trial of Tyvyt for NSCLC
Week in Review: BioKangtai Acquires China Rights to AstraZeneca's COVID-19 Vaccine
ABM Therapeutics Completes $20 Million Round for Neural Cancer Drugs
BioKangtai Strikes Deal to Supply AstraZeneca's COVID-19 Vaccine to China
Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China